A detailed history of First Washington Corp transactions in Vericel Corp stock. As of the latest transaction made, First Washington Corp holds 123,944 shares of VCEL stock, worth $6.48 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares
123,944
Previous 146,108 15.17%
Holding current value
$6.48 Million
Previous $5.2 Million 23.93%
% of portfolio
2.53%
Previous 2.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$32.52 - $52.33 $720,773 - $1.16 Million
-22,164 Reduced 15.17%
123,944 $6.45 Million
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $396,391 - $476,569
-12,849 Reduced 8.08%
146,108 $5.2 Million
Q3 2023

Nov 13, 2023

BUY
$31.69 - $39.25 $138,168 - $171,130
4,360 Added 2.82%
158,957 $5.33 Million
Q4 2022

Feb 13, 2023

BUY
$17.65 - $27.37 $190,902 - $296,033
10,816 Added 7.52%
154,597 $4.07 Million
Q3 2022

Nov 10, 2022

BUY
$22.62 - $32.54 $867,929 - $1.25 Million
38,370 Added 36.4%
143,781 $3.34 Million
Q2 2022

Aug 10, 2022

SELL
$22.88 - $39.45 $11,691 - $20,158
-511 Reduced 0.48%
105,411 $2.65 Million
Q1 2022

May 11, 2022

BUY
$31.69 - $43.29 $59,545 - $81,341
1,879 Added 1.81%
105,922 $4.05 Million
Q4 2021

Feb 10, 2022

SELL
$35.2 - $52.6 $18,409 - $27,509
-523 Reduced 0.5%
104,043 $4.09 Million
Q3 2021

Nov 12, 2021

BUY
$46.35 - $59.75 $2 Million - $2.58 Million
43,133 Added 70.21%
104,566 $5.1 Million
Q2 2021

Aug 12, 2021

SELL
$47.2 - $67.81 $1.94 Million - $2.79 Million
-41,120 Reduced 40.1%
61,433 $3.23 Million
Q1 2021

May 13, 2021

SELL
$30.93 - $59.48 $1.11 Million - $2.14 Million
-36,000 Reduced 25.98%
102,553 $5.7 Million
Q4 2020

Feb 11, 2021

SELL
$18.53 - $31.5 $29,851 - $50,746
-1,611 Reduced 1.15%
138,553 $4.28 Million
Q3 2020

Nov 13, 2020

BUY
$14.68 - $19.12 $88,080 - $114,720
6,000 Added 4.47%
140,164 $2.6 Million
Q2 2020

Aug 13, 2020

SELL
$8.5 - $15.82 $852,754 - $1.59 Million
-100,324 Reduced 42.78%
134,164 $1.85 Million
Q1 2020

May 08, 2020

SELL
$7.25 - $19.22 $1.47 Million - $3.91 Million
-203,354 Reduced 46.44%
234,488 $2.15 Million
Q4 2019

Feb 10, 2020

SELL
$13.77 - $19.2 $768,242 - $1.07 Million
-55,791 Reduced 11.3%
437,842 $7.62 Million
Q2 2019

Aug 14, 2019

BUY
$15.01 - $18.89 $82,555 - $103,895
5,500 Added 1.13%
493,633 $9.33 Million
Q1 2019

May 15, 2019

SELL
$16.23 - $20.29 $317,166 - $396,507
-19,542 Reduced 3.85%
488,133 $8.55 Million
Q4 2018

Feb 08, 2019

SELL
$10.77 - $18.44 $1.58 Million - $2.71 Million
-146,875 Reduced 22.44%
507,675 $8.83 Million
Q3 2018

Nov 13, 2018

SELL
$9.1 - $14.8 $18,200 - $29,600
-2,000 Reduced 0.3%
654,550 $9.26 Million
Q2 2018

Aug 10, 2018

BUY
$9.6 - $14.6 $992,448 - $1.51 Million
103,380 Added 18.69%
656,550 $6.37 Million
Q1 2018

May 04, 2018

SELL
$5.7 - $12.3 $1.46 Million - $3.15 Million
-255,857 Reduced 31.63%
553,170 $5.5 Million
Q4 2017

Feb 07, 2018

BUY
$3.65 - $5.98 $494,940 - $810,888
135,600 Added 20.14%
809,027 $4.41 Million
Q3 2017

Nov 07, 2017

BUY
$3.0 - $6.0 $2.02 Million - $4.04 Million
673,427
673,427 $4.04 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.47B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track First Washington Corp Portfolio

Follow First Washington Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Washington Corp with notifications on news.